H.C. Wainwright Upgrades Cardiff Oncology (CRDF) to Buy
H.C. Wainwright analyst Raghuram Selvaraju upgraded Cardiff Oncology (NASDAQ: CRDF) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
